About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of Oglemilast for the Prevention of Asthma.

NCT00322283·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Forest Laboratories

Age

18–50

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

stable mild asthma patients who exhibit at least a 20% decrease in FEV1 following exercise.

You may not be if

pulmonary disease other than asthma, psychiatric illness, active cardiac disease, high blood pressure, history of substance abuse, current smokers.

The record

StatusCompleted

PhasePhase 2

Taking part24

StartedMay 2006

UpdatedApr 10, 2012

Conditions

Exercise-Induced Asthma

Where2

Forest Investigative Site
Los Angeles, California, United States
Forest Investigative Site
North Dartmouth, Massachusetts, United States

Clareo Health | Study of Oglemilast for the Prevention of Asthma.